Hepatitis B virus still under debate;L'hépatite virale B, encore et toujours d'actualité

Archives de Pediatrie

Volumn 13, Issue 9, 2006, Pages 1269-1274

  Ajana, F ^a  

^a CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

Epidemiology; Hepatitis B virus; Outcome; Prophylaxis

Indexed keywords

ADEFOVIR DIPIVOXIL; ENTECAVIR; HEPATITIS B VACCINE; LAMIVUDINE; TENOFOVIR DISOPROXIL; VIRUS VACCINE;

ARTICLE; CHILD; FETOPLACENTAL UNIT; FRANCE; GENETIC VARIABILITY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; INCIDENCE; INFECTION COMPLICATION; INFECTION PREVENTION; PAPILLOMA VIRUS; PREVALENCE; RISK; SEXUALLY TRANSMITTED DISEASE; SUPERINFECTION; TREATMENT OUTCOME; VACCINATION; VIRUS HEPATITIS; VIRUS STRAIN;

HEPATITIS B; HEPATITIS B VACCINES; HUMANS;

EID: 33748329464     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.06.014     Document Type: Article

References (12)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11 (2004) 97-107
2. Denis F., Alain S., and Ratti-Loustaud V. Virus des hépatites B et Delta (2004), Elsevier, Paris
3. Custer B., Sullivan S.D., Hazlet T.K., Iloeje U., Veenstra D.L., and Kowdley K.V. Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol. 38 Suppl 10 (2004) S158-S168
4. Conférence internationale de consensus sur la vaccination anti-hépatite B. Paris, 10-11 septembre (2003)
5. Avis du Conseil supérieur d'hygiène public de France relatif à la vaccination des nouveau-nés de mères porteuses de l'hépatite B. Séance du 20 janvier 2006, inspirée du Guide des vaccinations 2003, consultable sur www.sante.gouv.fr
6. Conférence de consensus sur la co-infection VIH + VHB/VHC. Paris, 2-3 mars (2005)
7. Mele A., Tancredi F., Romano L., Giuseppone A., Colucci M., and Sangiuolo A. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J. Infect. Dis. 184 (2001) 905-908
8. Ngui S.L., Andrews N.J., Underhill G.S., Heptonstall J., and Teo C.G. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin. Infect. Dis. 27 (1998) 100-106
9. Wagner A.A., Denis F., Ranger-Rogez S., Constaud-Ratti V., and Alain S. Génotypes du virus de l'hépatite B. IBS 19 (2004) 330-342
10. Zoulim F., Poynard T., Degos F., Slama A., El Hasnaoui A., Blin P., et al. The Lamivir Study Group. A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine. J. Viral Hepat. 13 (2006) 278-288
11. Schildgen O., Sirma H., Funk A., Olotu C., Wend U.C., and Hartmann H. Variant of hepatitis B with primary resistance to adefovir. N. Engl. J. Med. 354 (2006) 1807-1812
12. Anaes ou HAS. Diagnostic et suivi virologiques des hépatites virales (à l'exclusion du dépistage en cas de dons de sang, d'organes ou de tissus). Actualisation des recommandations et références médicales ; 2001.